Drug-coated balloon outcomes in contemporary PCI: exploratory analysis by drug class and device
Introduction and objectives:To explore potential differences by drug class and device among contemporary coronary drug-coated balloons (DCBs).Methods: We conducted a national, 4-center, observational, retrospective study including all-comer patients undergoing DCB-based percutaneous coronary intervention between January 2023 and December 2024.Patients treated with more than 1 DCB brand were excluded.Patients were followed up for 1 year.The primary endpoint was target lesion failure (TLF), defined as a composite of cardiac death, target vessel-related myocardial infarction (TVMI), and clinically driven target lesion revascularization (TLR).To assess drug-and device-level effects, inverse probability of treatment weighting based on propensity scores was applied, and outcomes were analyzed using Cox proportional hazards models with clustering at the patient level.Results: A total of 1018 patients (1359 lesions) were included.At 1 year, TLF rates were similar between paclitaxel-and sirolimus-coated balloons (6.2% vs 4.6%; P = .204),with no significant difference after adjustment (HR, 1.22; 95%CI, 0.71-2.10;P = .474).Among paclitaxel-coated balloons, no significant differences in TLF were observed across the 3 devices.In contrast, among sirolimus-coated balloons, treatment with a microreservoir-based balloon was associated with a lower observed risk of TLF compared with a nanoparticle-based balloon (HR, 0.17; 95%CI, 0.05-0.58;P = .004).Conclusions: In this real-world multicenter study, paclitaxel-and sirolimus-coated balloons showed comparable 1-year outcomes.While paclitaxel devices demonstrated consistent performance across platforms, outcomes differed among sirolimus-coated balloons.The device-level findings should be considered exploratory and hypothesis-generating because of the limited number of events and the residual risk of confounding.
Authors
- Hugo Vinhas
- David Neves (ORCID: https://orcid.org/0000-0003-3797-8224)
- Daniel Faria (ORCID: https://orcid.org/0000-0003-3837-6786)
- Ana Esteves
- and Francisco Soares
- Lucas Hamann
Institutions
- Hospital de Faro EPE (PT)
- Hospital do Espírito Santo (PT)
- Hospital de São Bernardo (PT)
- Hospital de Santo André (PT)
- Unidade Local de Saúde da Arrábida (PT)
- Unidade Local de Saúde do Algarve (PT)
- Unidade Local de Saúde da Região de Leiria (PT)
- Unidade Local de Saúde do Alentejo Central (PT)
Publication Details
- Journal
- REC interventional cardiology (English Edition)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.24875/recice.m26000628
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00